Infusion of FK506, a specific inhibitor of calcineurin, induces potent tau hyperphosphorylation in mouse brain

Brain Research Bulletin

Volumn 76, Issue 5, 2008, Pages 464-468

  Luo, Jing ^a   Ma, Jie ^a   Yu, Da Yu ^a   Bu, Fan ^a   Zhang, Wen ^a   Tu, Ling Hui ^a   Wei, Qun ^a  

^a BEIJING NORMAL UNIVERSITY   (China)

Author keywords

Brain ventricle; Calcineurin activity; Cyclosporin A; Inhibitor; Phosphatase; Tau phosphorylation

Indexed keywords

CALCINEURIN; CYCLOSPORIN A; SERINE; TACROLIMUS; TAU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN VENTRICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; BRAIN; CALCINEURIN; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; MALE; MICE; MICE, INBRED BALB C; PHOSPHORYLATION; TACROLIMUS; TAU PROTEINS;

EID: 44549086153     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2007.12.005     Document Type: Article

References (23)

1. Bennett P.C., Zhao W.Q., Lawen A., and Ng K.T. Cyclosporin A, an inhibitor of calcineurin, impairs memory formation in day-old chicks. Brain Res. 73 (1996) 107-117
2. Clipstone N.A., and Crabtree G.R. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 35 (1992) 695-697
3. Hernandez-Espinosa D., and Morton A.J. Calcineurin inhibitors cause an acceleration of the neurological phenotype in a mouse transgenic for the human Huntington's disease mutation. Brain Res. Bull. 69 (2006) 669-679
4. Fruman D.A., Pai S.Y., Klee C.B., Burakoff S.J., and Bierer B.E. Measurement of calcineurin phosphatase activity in cell extracts. Methods: A Companion Methods Enzymol. 9 (1996) 146-154
5. Garver T.D., Kincaid R.L., Conn R.A., and Billingsley M.L. Reduction of calcineurin activity in brain by antisense oligonucleotides leads to persistent phosphorylation of tau protein at Thr181 and Thr231. Mol. Pharmacol. 55 (1999) 632-641
6. Goedert M. Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci. 16 (1993) 460-465
7. Iqbal K., Alonso A.C., Gondal J.A., Gong C.X., Haque N., Khatoon S., Sengupta A., Wang J.Z., and Grundke-Iqbal I. Inhibition of neurofibrillary degeneration: a rational and promising therapeutic target. In: Iqbal K., Sweab D.F., Winblad B., and Wisniewski H.M. (Eds). Alzheimer's Disease and Related Disorders (1999), Wiley, New York 643-654
8. Jiang G.H., and Wei Q. Function and structure of N-terminal and C-terminal domains of calcineurin B subunit. Biol. Chem. 384 (2003) 1299-1303
9. Johnson G.V.W., and Stoothoff W.H. Tau phosphorylation in neuronal cell function and dysfunction. J. Cell Sci. 117 (2004) 5721-5729
10. Kayyali U.S., Zhang W., Yee A.G., Seidman J.G., and Potter H. Cytoskeletal change in the brains of mice lacking calcineurin Aα. J. Neurochem. 68 (1997) 1668-1678
11. Kung L., Batiuk T.D., Palomo-Pinon S., Noujaim J., Helms L.M.H., and Halloran P.F. Tissue distribution of calcineurin and its sensitivity to inhibition by cyclosporine. Am. J. Transpl. 1 (2001) 325-333
12. Kung L., and Halloran P.F. Immunophilins may limit calcineurin inhibition by cyclosporine and tacrolimus at high drug concentrations. Transplantation 70 (2000) 327-335
13. Liu J., Farmer Jr. J.D., Lane W.S., Friedman J., Weissman I., and Schreiber S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66 (1991) 807-815
14. Liu F., Grundke-Iqbal I., Iqbal K., and Gong C.X. Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur. J. Neurosci. 22 (2005) 1942-1950
15. Luo J., Lou A.I., and Wei Q. Effects of calcineurin on LTP of rats in vivo. Chin. Sci. Bull. 47 (2002) 476-479
16. Luo J., and Wei Q. Relationship between LTP and nuclear protein induced by calcineurin. Chin. Sci. Bull. 43 (1998) 1384-1387
17. Perrino B.A., Fong Y.L., Brickey D.A., Saitoh Y., Ushio Y., Fukunaga K., Miyamoto E., and Soderling T.R. Characterization of the phosphatase activity of a baculovirus-expressed calcineurin A isoform. J. Biol. Chem. 267 (1992) 15965-15969
18. Perrino B.A., Wilson A.J., Ellison P., and Clapp L.H. Substrate selectivity and sensitivity to inhibition by FK506 and cyclosporin A of calcineurin heterodimers composed of the {alpha} or {beta} catalytic subunit. FEBS J. 269 (2002) 3540-3548
19. Rusnak F., and Mertz P. Calcineurin: form and function. Physiol. Rev. 80 (2000) 1483-1521
20. Wei Q., Holzer M., Brueckner M.K., Liu Y., and Arendt T. Dephosphorylation of tau protein by calcineurin triturated into neural living cells. Cell Mol. Neurobiol. 22 (2002) 13-24
21. Xiang B.Q., Liu P., Jiang G.H., Zou K., Yi F., Yang S.J., and Wei Q. The catalytically active domain in the A subunit of calcineurin. Biol. Chem. 384 (2003) 1429-1434
22. Yan L.J., and Wei Q. High activity of the calcineurin A subunit with a V314 deletion. Biol. Chem. 380 (1999) 1281-1285
23. Yu D.Y., Luo J., Bu F., Song G.J., and Wei Q. Inhibition of calcineurin by infusion of CsA causes hyperphosphorylation of tau, accompanied by abnormal behavior in mice. Biol. Chem. 387 (2006) 977-983